189 related articles for article (PubMed ID: 2988126)
21. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
[TBL] [Abstract][Full Text] [Related]
22. Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro.
Aley SB; Bates MD; Tam JP; Hollingdale MR
J Exp Med; 1986 Dec; 164(6):1915-22. PubMed ID: 3023519
[TBL] [Abstract][Full Text] [Related]
23. Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology.
Okitsu SL; Mueller MS; Amacker M; Vogel D; Westerfeld N; Robinson JA; Zurbriggen R; Pluschke G
Hum Vaccin; 2008; 4(2):106-14. PubMed ID: 18382133
[TBL] [Abstract][Full Text] [Related]
24. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein.
Moreno A; Clavijo P; Edelman R; Davis J; Sztein M; Herrington D; Nardin E
Int Immunol; 1991 Oct; 3(10):997-1003. PubMed ID: 1721837
[TBL] [Abstract][Full Text] [Related]
27. The malaria sporozoite vaccine: parasitology's brave new world.
Spriggs DR
J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830
[No Abstract] [Full Text] [Related]
28. Human T cells recognize polymorphic and non-polymorphic regions of the Plasmodium falciparum circumsporozoite protein.
Guttinger M; Caspers P; Takacs B; Trzeciak A; Gillessen D; Pink JR; Sinigaglia F
EMBO J; 1988 Aug; 7(8):2555-8. PubMed ID: 2461298
[TBL] [Abstract][Full Text] [Related]
29. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes.
Hollingdale MR; Appiah A; Leland P; do Rosario VE; Mazier D; Pied S; Herrington DA; Chulay JD; Ballou WR; Derks T
Trans R Soc Trop Med Hyg; 1990; 84(3):325-9. PubMed ID: 2175464
[TBL] [Abstract][Full Text] [Related]
30. Interaction of Malaysian sera with Plasmodium vivax sporozoite antigen.
Lee M; Davis DR; Ballou WR; Folena-Wasserman G; Lewis GE
Am J Trop Med Hyg; 1988 Dec; 39(6):535-9. PubMed ID: 3061309
[TBL] [Abstract][Full Text] [Related]
31. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.
Malik A; Egan JE; Houghten RA; Sadoff JC; Hoffman SL
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3300-4. PubMed ID: 1707538
[TBL] [Abstract][Full Text] [Related]
32. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
33. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
Rzepczyk CM; Csurhes PA; Lord R; Matile H
J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
[TBL] [Abstract][Full Text] [Related]
34. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
Hoffman SL; Oster CN; Plowe CV; Woollett GR; Beier JC; Chulay JD; Wirtz RA; Hollingdale MR; Mugambi M
Science; 1987 Aug; 237(4815):639-42. PubMed ID: 3299709
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide.
Gysin J; Barnwell J; Schlesinger DH; Nussenzweig V; Nussenzweig RS
J Exp Med; 1984 Sep; 160(3):935-40. PubMed ID: 6470623
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
[TBL] [Abstract][Full Text] [Related]
38. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
Del Giudice G; Tougne C; Louis JA; Lambert PH; Bianchi E; Bonelli F; Chiappinelli L; Pessi A
Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
[TBL] [Abstract][Full Text] [Related]
40. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
Iqbal J; Rab A; Perlmann P; Berzins K
Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
